Molecular Testing Labs on Behalf of Ascendant Strategic Partners
Diagnostic testing
Based in WA
🤖
AI Overview
With $0 in lobbying spend across 4 quarterly filings, Molecular Testing Labs on Behalf of Ascendant Strategic Partners is an active lobbying client. Their lobbying covers 1 issue area.
$0
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Regulation of diagnostic tests (including H.R. 4128, the VALID Act of 2021), and use of diagnostic tests to improve public health
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Providence St. Joseph Health
$4.3M total spend
Seattle Children's Hospital Research and Foundation
$2.1M total spend
King County
$2.0M total spend
Seattle Children's Hospital Research and Foundation
$2.0M total spend
Fred Hutchinson Cancer Center (Formerly Known as Seattle Cancer Care Alliance)
$1.7M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.